{"id":13257,"date":"2020-12-23T00:00:00","date_gmt":"2020-12-23T00:00:00","guid":{"rendered":"https:\/\/clinlabint.3wstaging.nl\/biorad-introduces-platelia-sars-cov-2-total-ab-assay\/"},"modified":"2020-12-23T00:00:00","modified_gmt":"2020-12-23T00:00:00","slug":"biorad-introduces-platelia-sars-cov-2-total-ab-assay","status":"publish","type":"post","link":"https:\/\/clinlabint.com\/biorad-introduces-platelia-sars-cov-2-total-ab-assay\/","title":{"rendered":"Biorad introduces Platelia SARS-CoV-2 Total Ab assay"},"content":{"rendered":"
As COVID-19 continues to impact countries worldwide, accurate screening is needed to establish serological status of different populations. Bio-Rad now offers the Platelia SARS-CoV-2 Total Ab assay, for the detection of total anti-nucleocapsid antibodies (IgM, IgA, IgG) to SARS-CoV-2. In one test, the assay helps identify the immune response to coronavirus SARS-CoV-2, the virus associated with COVID-19.
\nFor more information, visit: https:\/\/info.bio-rad. com\/cdg-sars-cov-2-ous?WT.mc_id=200814028804<\/link>\n
\nSupplier:<\/strong> Bio-Rad Laboratories
\nWebsite:<\/strong> https:\/\/info.bio-rad.com\/cdg-sars-cov-2-ous?WT.mc_id=200814028804<\/a><\/p>\n